|
PREP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.027600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.607700E-02 |
| Normal-vs-Stage2 |
2.863200E-01 |
| Normal-vs-Stage3 |
8.560400E-01 |
| Normal-vs-Stage4 |
6.482200E-01 |
| Stage1-vs-Stage2 |
7.577400E-01 |
| Stage1-vs-Stage3 |
3.191900E-02 |
| Stage1-vs-Stage4 |
3.059000E-01 |
| Stage2-vs-Stage3 |
2.518000E-01 |
| Stage2-vs-Stage4 |
5.869200E-01 |
| Stage3-vs-Stage4 |
5.774400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.377810E-01 |
| Normal-vs-AfricanAmerican |
4.189600E-01 |
| Normal-vs-Asian |
6.908100E-02 |
| Caucasian-vs-AfricanAmerican |
8.265400E-01 |
| Caucasian-vs-Asian |
2.429000E-01 |
| AfricanAmerican-vs-Asian |
6.139600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.700800E-01 |
| Normal-vs-Female |
4.138400E-02 |
| Male-vs-Female |
5.882100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.606100E-02 |
| Normal-vs-Age(41-60Yrs) |
4.522400E-01 |
| Normal-vs-Age(61-80Yrs) |
6.296200E-01 |
| Normal-vs-Age(81-100Yrs) |
6.890400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.492440E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.180630E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.321200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.227000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.398000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.196800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.047800E-01 |
| Classical-VS-Follicular |
8.832200E-01 |
| Classical-VS-Other |
2.778600E-01 |
| Classical-VS-Normal |
3.860200E-02 |
| Tall-VS-Follicular |
3.681800E-01 |
| Tall-VS-Other |
7.026000E-01 |
| Tall-VS-Normal |
9.586800E-01 |
| Follicular-VS-Other |
4.771200E-01 |
| Follicular-VS-Normal |
2.501000E-01 |
| Other-VS-Normal |
5.382400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.693600E-01 |
| Normal-vs-N1 |
7.111200E-01 |
| N0-vs-N1 |
2.628000E-01 |
|
|
